1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Drug Modelling Software Market – By Product Type

1.3.2        Europe Drug Modelling Software Market – By Application

1.3.3        Europe Drug Modelling Software Market – By Country

2.           Europe Drug Modelling Software Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Drug Modelling Software Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Drug Modelling Software Market - Europe PEST Analysis

4.3         Expert Opinion

5.           Europe Drug Modelling Software Market -  Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Adoption of Modelling Tools in Drug Discovery

5.1.2        Increasing Economic Burden of Drug Discovery

5.2         Key Market Restraints

5.2.1        Lack of Data Standardization

5.3         Key Market Opportunities

5.3.1        Strategic Activities by Market Players

5.4         Future Trends

5.4.1        Growing Adoption of Artificial Intelligence in Drug Discovery

5.5         Impact analysis

6.           Drug Modelling Software Market – Europe Analysis

6.1         Europe Drug Modelling Software Market Revenue Forecasts and Analysis

7.           Europe Drug Modelling Software Market Analysis and Forecasts To 2027 – By Product Type

7.1         Overview

7.2         Europe Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

7.2.1        Europe Drug Modelling Software Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)

7.3         Database

7.3.1        Overview

7.3.2        Europe Database Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Software

7.4.1        Overview

7.4.1.1          Europe Software Revenue and Forecasts to 2027 (US$ Mn)

7.5         Other Product Types

7.5.1        Overview

7.5.2        Europe Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)

8.           Europe Drug Modelling Software Market Analysis and Forecasts To 2027 – By Application

8.1         Overview

8.2         Europe Drug Modelling Software Market, By Application 2019 & 2027 (%)

8.2.1        Europe Drug Modelling Software Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Drug Discovery and Development

8.3.1        Overview

8.3.2        Europe Drug Discovery and Development Market Revenue and Forecast to 2027 (US$ Mn)

8.4         Computational Physiological Medicine

8.4.1        Overview

8.4.2        Europe Computational Physiological Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Disease Modelling

8.5.1        Overview

8.5.2        Europe Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Medical Imaging

8.6.1        Overview

8.6.2        Europe Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Predictive Analysis of Drug Targets

8.7.1        Overview

8.7.2        Europe Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

8.8         Simulation Software

8.8.1        Overview

8.8.2        Europe Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

8.9         Cellular Simulation

8.9.1        Overview

8.9.2        Europe Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

8.10      Others

8.10.1     Overview

8.10.2     Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Drug Modelling Software Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         Europe Drug modelling software Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        Europe: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.3        Europe: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.4        Europe: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.5        Europe: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

9.1.6        Germany: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          Germany: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          Germany: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          Germany: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.7        France: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          France: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          France: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.7.3          France: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.8        UK: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          UK: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          UK: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.3          UK: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.9        Italy: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1          Italy: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2          Italy: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.9.3          Italy: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.10     Spain: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1       Spain: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2       Spain: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.10.3       Spain: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on Europe Drug Modelling Software Market

10.1      Europe: Impact Assessment of COVID-19 Pandemic

11.        Company Profiles

11.1      Genedata AG

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Biognos AB

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Dassault Systèmes

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Acellera

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.5      Crown Bioscience Inc (JSR life science)

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Europe Drug Modelling Software Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)

Table 2.             Europe Drug Modelling Software Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.             Europe: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 4.             Europe: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 5.             Germany: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Germany: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 7.             France: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 8.             France: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             UK: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          UK: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          Italy: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 12.          Italy: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 13.          Spain: Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Spain: Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 15.          Glossary of Terms, Drug Modelling Software Market

LIST OF FIGURES

Figure 1.           Drug Modelling Software Market Segmentation

Figure 2.           Europe Drug Modelling Software Market Overview

Figure 3.           Software Segment Held Largest Share of Drug Modelling Software Market

Figure 4.           UK is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Europe Drug Modelling Software Market - Leading Country Markets (US$ Mn)

Figure 6.           Drug Modelling Software Market - Europe PEST Analysis

Figure 7.           Drug Modelling Software Market Impact Analysis of Driver and Restraints

Figure 8.           Europe Drug Modelling Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Europe Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

Figure 10.        Europe Database Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Europe Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Europe Other Product Types Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Europe Drug Modelling Software Market, By Application 2019 & 2027 (%)

Figure 14.        Europe Drug Discovery and Development Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Europe Computational Physiological Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Europe Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Europe Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Europe Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Europe Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Europe Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Europe Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Europe: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        Europe: Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        Europe: Drug Modelling Software Market, by Country, 2019 & 2027 (%)

Figure 25.        Germany: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        France: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        UK: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Italy: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Spain: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        Impact of COVID-19 Pandemic in European Country Markets